2m 2m 2m 2m 2m 2m 2m
Pennant Group (PNTG)
NASDAQ
$34.22+$0.59 (+1.74%)
Price as of Jun 23, 2026 5:39 PM EDT- $1.2BMarket Cap
- 19.17%1-Year Change
- Medical Care FacilitiesIndustry
Pennant Group (PNTG)
$34.22+$0.59 (+1.74%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 947.7M +36.31% | 695.2M +27.59% | 544.9M +15.14% | 473.2M +7.63% | |
Cost of Revenue | 768.5M +37.61% | 558.4M +27.47% | 438.1M +16.32% | 376.6M +6.67% | |
Gross Profit | 179.2M +31.00% | 136.8M +28.09% | 106.8M +10.55% | 96.6M +11.55% | |
Sales and Marketing Expense | 71.1M +41.56% | 50.2M +36.93% | 36.7M N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 8.5M +39.53% | 6.1M +19.28% | 5.1M +4.69% | 4.9M +2.42% | |
Total Operating Expenses | 895.8M +36.32% | 657.1M +26.44% | 519.7M +12.86% | 460.5M +5.86% | |
Operating Profit | 51.9M +36.13% | 38.1M +51.44% | 25.2M +97.57% | 12.7M +171.33% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -6.3M -7.30% | -6.7M +13.93% | -5.9M +55.24% | -3.8M +96.60% | |
Interest Income and Expense and Net | -6.3M -7.30% | -6.7M +13.93% | -5.9M +55.24% | -3.8M +96.60% | |
Total Nonoperating Income and Expense | 422,000 +103.86% | 207,000 -38.94% | 339,000 +1,193.55% | -31,000 +29.17% | |
Income before Taxes | 45.6M +45.47% | 31.4M +60.17% | 19.6M +120.24% | 8.9M +225.71% | |
Income Taxes | 11.9M +68.84% | 7.0M +23.86% | 5.7M +244.09% | 1.6M +183.33% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | 29.6M +31.11% | 22.6M +68.61% | 13.4M +101.40% | 6.6M +146.40% | |
Net Income from Continuing Operations Applicable to Common | 45.6M +45.47% | 31.4M +60.17% | 19.6M +120.24% | 8.9M +225.71% | |
Basic EPS and Net Income | 0.86 +19.44% | 0.72 +60.00% | 0.45 +95.65% | 0.23 +155.56% | |
Diluted EPS and Net Income | 0.84 +20.00% | 0.70 +59.09% | 0.44 +100.00% | 0.22 +144.44% | |
Basic Weighted Average Shares | 34.6M +10.81% | 31.2M +4.45% | 29.9M +2.75% | 29.1M +2.32% | |
Diluted Weighted Average Shares | 35.3M +10.36% | 32.0M +5.98% | 30.2M +0.11% | 30.2M -1.58% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 17.0M -29.79% | 24.2M +300.17% | 6.1M +191.44% | 2.1M -59.94% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 17.0M -29.79% | 24.2M +300.17% | 6.1M +191.44% | 2.1M -59.94% | |
Total Current Assets | 167.4M +36.26% | 122.9M +53.42% | 80.1M +8.47% | 73.8M -2.66% | |
Accumulated Depreciation | 35.5M +24.65% | 28.4M +13.45% | 25.1M +20.52% | 20.8M +12.56% | |
Property and Plant and Equipment and Net | 61.0M +40.85% | 43.3M +51.40% | 28.6M +7.43% | 26.6M +58.57% | |
Total Long-Term Assets | 61.0M +40.85% | 43.3M +51.40% | 28.6M +7.43% | 26.6M +58.57% | |
Total Assets | 968.2M +42.48% | 679.5M +25.91% | 539.7M +5.38% | 512.1M -3.43% | |
Income Taxes Payable | 150,000 -91.94% | 1.9M +0.32% | 1.9M +80.62% | 1.0M -6.81% | |
Total Short-Term Debt | 5.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 147.3M +44.80% | 101.7M +42.14% | 71.5M +1.85% | 70.2M -1.94% | |
Total Long-Term Debt | 168.8M N/A | 0 -100.00% | 63.9M +1.63% | 62.9M +22.42% | |
Total Long-Term Liabilities | 23.4M +120.95% | 10.6M +28.00% | 8.3M +31.54% | 6.3M +18.67% | |
Total Liabilities | 593.9M +61.59% | 367.6M -6.75% | 394.2M +2.00% | 386.5M -7.11% | |
Retained Earnings | 86.8M +51.69% | 57.2M +65.08% | 34.7M +62.86% | 21.3M +45.37% | |
Total Stockholders Equity | 332.6M +13.41% | 293.3M +108.98% | 140.3M +15.97% | 121.0M +9.81% | |
Total Shares Outstanding | 34.6M +0.74% | 34.4M +14.78% | 29.9M +0.86% | 29.7M +4.19% | |
Cash Flow | |||||
Cash from Operating Activities | 48.3M +22.89% | 39.3M +18.76% | 33.1M +265.88% | 9.0M +149.63% | |
Capital Expenditures | 12.0M +33.89% | 9.0M +10.94% | 8.1M -42.80% | 14.2M +124.81% | |
Cash from Investing Activities | -228.0M +222.52% | -70.7M +133.88% | -30.2M +24.68% | -24.2M +20.47% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 172.5M +247.88% | 49.6M +4,358.00% | 1.1M -90.80% | 12.1M -72.21% | |
Financials Ratio | |||||
Gross Margin | 18.91% -3.90% | 19.68% +0.39% | 19.60% -3.99% | 20.41% +3.64% | |
Operating Margin | 5.47% -0.14% | 5.48% +18.69% | 4.62% +71.59% | 2.69% +152.10% | |
Return on Assets | 3.59% -2.98% | 3.70% +45.46% | 2.54% +99.61% | 1.27% +145.19% | |
Return on Equity | 9.45% -9.16% | 10.40% +1.63% | 10.24% +78.17% | 5.75% +120.37% | |
Revenue Growth | 36.31% +31.61% | 27.59% +82.25% | 15.14% +98.44% | 7.63% -38.80% | |
Current Ratio | 1.14 -5.89% | 1.21 +7.93% | 1.12 +6.50% | 1.05 -0.74% | |
Cash Ratio | 0.12 -51.51% | 0.24 +181.46% | 0.08 +186.15% | 0.03 -59.17% | |
Debt-to-Equity Ratio | 0.52 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.18 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow